Months after Pfizer and Mylan's generics spinoff Viatris sketched out a $1 billion cost-cutting initiative, the company is telegraphing details around the closure of a major U.S. plant formerly operated by Mylan.
Viatris is due to shutter manufacturing operations at its oral solid dose plant in Morgantown, West Virginia, on July 31. That same day, a majority of some 1,431 layoffs there are expected to go into effect, The Dominion Post reported Thursday, citing a Worker Adjustment and Retraining Notification (WARN) Act notice Viatris sent to local authorities this week.
Hiring? Create your free Drafted account
Create you free account to join companies like Better.com and Karat who use Drafted to power their referral hiring.
The Layoff List was created in 2019 and is free for the community. Tips reported are left anonymous unless they explicitly ask to be included as a source. We verify a majority of tips and include independent sources, but for tips that we are unable to verify we separately categorize them as unverified reports to avoid misrepresentations.